-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602. Myeloid Oncogenesis: Basic: Poster III

Symposia: Myeloid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Nayeli Esparza1*, Eva Bresson2*, Safia Safa-Tahar-Henni3*, Joan Defrene2*, Élodie Roques3*, Florence Bonnet-Magnaval3*, Vincent-Philippe Lavallée4*, Brian T. Wilhelm, PhD, BSc5* and Frederic Barabe, MD6

1Laval University, Québec, QC, Canada
2Laval University, Québec, Canada
3University of Montreal, Montreal, QC, CAN
4Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC, CAN
5Institute for Research in Immunology and Cancer of the University of Montreal, Montreal, QC, Canada
6Hôpital de l'Enfant-Jésus, Division of Hematology and Medical Oncology, CHU de Québec - Université Laval, Québec, QC, Canada

Adnan K. Mookhtiar, MSc1, Hidehiro Itonaga, MD, PhD1,2, Sarah Greenblatt, PhD1*, Concepcion Martinez, MS1*, Jun Sun, PhD1*, Krystal Lisa Hossack, MS1*, Ramin Shiekhattar, PhD1*, Daniel Bilbao, PhD3, Maria Ken E. Figueroa, MD1, Simone Sidoli, PhD4* and Stephen D. Nimer, MD1

1University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
2Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki city, NSK, Japan
3Cancer Modeling Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
4Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY

Jelena Milosevic, PhD1*, Johannes Elferich, PhD2*, Kashish Chetal3*, Mary Ayres4*, Varsha Gandhi, PhD5, Ruslan Sadreyev, PhD3*, Nikolaus Grigorieff, PhD2*, Shobha Vasudevan, PhD6* and David Sykes, MD, PhD7

1Center for Regenerative Medicine, MGH, Boston, MA
2Howard Hughes Medical Institute, University of Massachusetts Chan Medical School, Worcester, MA
3Department of Molecular Biology, Massachusetts General Hospital, Boston, MA
4Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX
5Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
6MGH, HMS, BOSTON, MA
7The Massachusetts General Hospital, Boston, MA

Takayuki Hoshii, PhD1*, Sota Kikuchi1*, Seito Shibata1*, Makoto Matsumoto1*, Bahityar Rahmutulla2*, Masaki Fukuyo3*, Scott A Armstrong, MD, PhD4 and Atsushi Kaneda2*

1Chiba University, Chiba, Japan
2Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
3Chiba University, Chiba, JA, Japan
4Pediatric Oncology, Dana-Farber Cancer Institute, Boston

Zhe Chen1*, Feng Wu2*, Lei Li3* and Yu Hou, PhD4

1Institute of Life Sciences, Chongqing Medical University, Chongqing, China
2Institute of Life Sciences, Chongqing Medical University, chongqing, China
3Institute of Life Sciences, Chongqing Medical Univerity, Chongqing, China
4Institute of Life Sciences, Chongqing Medical University, CHONGQING, Chongqing, China

Miranda Fernandez-Serrano, MSc1,2*, Alba Mesa, MD3*, Ignacio Campillo-Marcos, PhD4,5*, Marta Casado-Pelaez4*, Shubhra Bhattacharya6*, Laura Palomo, PhD7*, Wencke Walter, PhD8*, Pau Marin-Escudero, MSc1*, Mar Mallo9*, Julia Montoro10*, Francesc Sole, PhD11, Elisabetta Mereu, PhD12*, Caterina Mata13*, David Corujo, PhD6*, Torsten Haferlach, MD, PhD8, Marcus Buschbeck, PhD14*, Manel Esteller, MD15,16,17,18, David Valcarcel, MD, PhD10, Silvia Saumell, MD, PhD19,20* and Gael Roue, PhD21

1Lymphoma Tranlastional group, Josep Carreras Leukaemia Research Institute, Badalona, Spain
2Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona (UAB), Barcelona, Spain
3Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, Badalona, Spain
4Cancer Epigenetics group, Josep Carreras Leukaemia Research Institute, Badalona, Spain
5Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain
6Chromatin, Metabolism and Cell Fate group, Josep Carreras Leukaemia Research Institute, Badalona, Spain
7Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
8MLL Munich Leukemia Laboratory, Munich, Germany
9Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
10Service of Hematology, Hospital Universitari Vall d’Hebron, Barcelona; Vall d’Hebron Instituto de Oncología (VHIO), Barcelona, Spain
11MDS Group, Josep Carreras Leukaemia Research Institut, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain
12Cellular Systems Genomics group, Josep Carreras Leukaemia Research Institute, Badalona, Spain
13Single Cell Unit, Josep Carreras Leukaemia Research Institute, Badalona, Spain
14Chromatin, Metabolism and Cell Fate group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, ESP
15Josep Carreras Leukaemia Research Institute, Badalona, Spain
16School of Medicine, Physiological Sciences Department, University of Barcelona, Badalona, Spain
17Centro de Investigacion Biomedica en Red Cancer, Madrid, Spain
18Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
19Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain
20Department of Hematology, University Hospital Vall d’Hebron, University Autònoma of Barcelona (UAB). Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, ESP
21Lymphoma translational group, Josep Carreras Leukemia Research Institute, Badalona, Spain

Xiaotu Ma, PhD1, Rhonda E Ries, MA2*, Quang Tran, PhD1*, Yanling Liu1*, Pandurang Kolekar, PhD1*, Ramzi Alsallaq1*, Zhikai Liang1*, Timothy Shaw3*, Meghana Devineni4*, Anne Deslattes Mays5*, Ching Lau5*, Johann K. Hitzler, MD6 and Soheil Meshinchi, MD, PhD7

1St. Jude Children's Research Hospital, Memphis, TN
2Translational Science and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA
3Moffitt Cancer Center, Tampa, FL
4Rhodes College, Memphis, TN
5The Jackson Laboratory for Genomic Medicine, farmington, CT
6Division Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, CAN
7Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA

Brian Chernak, MD1, Marta Galan-Diez, PhD2,3*, Abdullah Mahmood Ali, PhD4,5,6, Alvaro Cuesta-Dominguez, PhD2*, Ziwei Chen, PhD7*, Thomas Koehnke, MD8, Ravi Majeti, MD9, Martin Carroll, MD10, Azra Raza, MD4,6 and Stavroula Kousteni, PhD2,6

1Division of Hematology/Oncology, Columbia University Irving Medical Center, New York City, NY
2Department of Physiology and Cellular Biophysics, Columbia University Irving Medical Center, New York, NY
3Regeneron Pharmaceuticals, Tarrytown, NY
4Department of Medicine, Columbia University Irving Medical Center, New York, NY
5Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY
6Edward P. Evans Myelodysplastic Syndromes Center, Columbia University Irving Medical Center, New York, NY
7Department of Systems Biology, Columbia University Irving Medical Center, New York, NY
8Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA
9Stanford University School of Medicine, Stanford, CA
10Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA

Sean M. Post, PhD1, Kerstin Rhan, PhD1*, Shelley Herbrich, MS2*, Oscar Benitez3*, Ashley G Rodriguez, MS3*, Xiaorui Zhang, MS1*, Michael R Meier4*, Jared Brottem3*, Martina Crysandt, MD5*, Prerna Malaney, PhD6 and Isabel naarmann-Devries, PHD7*

1MD Anderson, Houston, TX
2UT MD Anderson, Houston, TX
3MD Anderson, Houston
4UT Health McWilliams School of Biomedical Informatics, Houston, TX
5Department of Hematology and Oncology, University Hospital RWTH Aachen and Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIOABCD), Aachen, Germany
6MD Anderson Cancer Centre, Houston, TX
7RWTH Aachen University, Aachen Germany, Aachen, Germany

Eirini Sofia Fasouli1*, Konstantina Giavi1*, Charikleia Makri1*, Leonid Bystrykh2*, Anthi Bouchla3*, Emmanouil Athanasiadis1*, Giannis Vatsellas1*, Vasiliki Pappa4* and Eleni Katsantoni5*

1Basic Research Center, Biomedical Research Foundation, Academy of Athens, Athens, Greece
2UMCG / University of Groningen, Groningen, Netherlands
3Hematology Unit, 2nd Department of Internal Medicine - Propaedeutic and Research Unit, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece
4Second Department of Internal Medicine and Research Institute, Hematology Unit, National and Kapodistrian University of Athens, Medical School, University General Hospital "Attikon", Athens, Greece
5Biomedical Research Foundation, Academy of Athens, Athens, Greece

Yoko Nishinaka-Arai, PhD, MT1,2*, Yohko Kitagawa, PhD3*, Yasuhiro Kazuki, PhD4*, Yasuyuki Arai, MD, PhD5, Tatsutoshi Nakahata, PhD, MD6*, Akira Niwa, MD, PhD3* and Megumu K Saito, MD, PhD3*

1Center for iPS cell research and application, Kyoto University, Kyoto, Japan
2Department of Human Health Sciences, Kyoto University, Kyoto, Japan
3Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
4Division of Genome and Cellular Functions, Department of Molecular and Cellular Biology, School of Life Science, Faculty of Medicine, Tottori University, Tottori, Japan
5Department of Hematology, Kyoto University Hospital, Kyoto, Japan
6Central institute for experimental animals, Kawasaki, Japan

Xiuhua Su*, Tao Sun*, Yuan Xia*, Mingying Li*, Dongmei Wang*, Fei Lu, MD*, Jingjing Ye* and Chunyan Ji, md, phd

Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China

Yuqing Dan*, Ruibao Ren, MD, PhD, Donghe Li, PhD* and Ping Liu, MD, PhD*

Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Yang Li1*, Haley Abel, PhD2*, Michelle Cai, MD3*, Taylor Lavalle4*, Tiankai Yin, BA5, Nichole Helton6*, Amanda Smith2*, Christopher A Miller, PhD6* and Timothy J Ley6

1Division of Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, Saint Louis, MO
2Washington University in St. Louis, St. Louis, MO
3Division of Oncology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO
4University of Missouri School of Medicine, Columbia, MO
5Washington University in St. Louis, Saint Louis, MO
6Division of Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO

Yanan Li, PhD1*, Wei Yang, PhD2*, Riddhi M. Patel1*, Emily B. Casey1*, Elisabeth Denby1* and Jeffrey Magee, MD, PhD3,4

1Department of Pediatrics, Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO
2Department of Genetics, Washington University School of Medicine, St. Louis, MO
3Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
4Washington University School of Medicine, Saint Louis, MO

Daelynn Buelow, PhD1*, Xining Yang, Ph.D2*, Deedra Nicolet3, Krzysztof Mrózek, MD, PhD4, Kathrin Krowiorz, PhD5*, Raj Bhayadia6*, Jack Stromatt7*, Anna Denny8*, Christoph Wiegel, Ph.D9*, Colin Corbett8*, Salma Abdelbaky9*, Yonger Xue8*, Yizhou Dong, PhD8*, Jeremy Hui2*, Arshia Shad2*, Sharon Gao2*, Si Wei Wu10*, Marion van den Bosch, PhD11*, Liam MacPhee2*, Leo Escano, BS12*, James S. Blachly13, Jonathan E Kolitz, MD14, William Blum, MD15, Maria R. Baer, MD16, Jan-Henning Klusmann, MD17, Ann-Kathrin Eisfeld, MD*3, Arefeh Rouhi, PhD2*, Sharyn D. Baker, PharmD18, Florian Kuchenbauer, MD, PhD, FRCPC19 and Christopher C. Oakes, PhD20

1Division of Pharmaceutics & Pharmacology, The Ohio State Univeristy, Lewis Center, OH
2Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada
3Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
4Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
5Division of Hematology and Oncology, University Hospital Ulm, Ulm, Germany
6Department of Pediatrics, Goethe University Frankfurt, Frankfurt (main), DEU
7Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH
8Division of Pharmaceutics & Pharmacology, The Ohio State University, Columbus, OH
9Division of Hematology, The Ohio State University, Columbus, OH
10Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, CAN
11InteRNA Technologies BV, Utrecht, Netherlands
12Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, Canada
13Department of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
14Zucker School of Medicine at Hofstra/Northwell, Zuckerberg Cancer Center, Lake Success, NY
15Winship Cancer Institute of Emory University, Atlanta, GA
16Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
17Goethe University Frankfurt, Frankfurt, Hessen, Germany
18Ohio State University, Columbus, OH
19BC Cancer Research Centre, Vancouver, BC, Canada
20Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH

Arjun Dhir, MSc1, Kevin Tur-Rodriguez1*, Samantha Swenson1*, Kasidy Weber1*, Abu Rafay2*, Vikas Kumar1*, Shannon M. Buckley, PhD3 and Kate Hyde, PhD4

1University of Nebraska Medical Center, Omaha, NE
2Northeastern University, Boston, MA
3University of Utah, SLC, UT
4Department of Biochemistry and Molecular Biology, and Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE

Rhea H. Desai1*, Peter J. Browett2, Purvi M. Kakadia1* and Stefan K. Bohlander1*

1Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
2University of Auckland School of Medicine, Auckland, NZL

Junli Mou1*, Yu Liu1*, Xiaoyu Liu1*, Runxia Gu, MD1*, Yingxi Xu, PhD1*, Kejing Tang1*, Zheng Tian1*, Haiyan Xing1*, Qing Rao, MS1*, Min Wang2*, Shaowei Qiu, MD3* and Jianxiang Wang, MD2

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
3National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Mengli Zhang1*, Shaela Wright2*, Xiaowen Chen3*, Ye Xin1*, Yingcai Jin1*, Jianxiang Zhang1*, Xue Yang1*, Xinfeng Chen1*, Judith Hyle2*, Wojciech Rosikiewicz4*, Beisi Xu, PhD2*, Liusheng He5*, Feiqiu Wen3*, Chunliang Li, PhD4 and Peng Xu, PhD6

1Soochow University, Suzhou, China
2St. Jude Children's Research Hospital, Memphis
3Shenzhen Children's Hospital, shenzhen, China
4St. Jude Children's Research Hospital, Memphis, TN
5Core Facility of Flow Cytometry, St. Jude Children's Research Hospital, Memphis
6Hematology Center, Cyrus Tang Medical Institute, Soochow University, Suzhou, Jiang Su, China

Jiexian Ma1*, Shunrong Sun1*, Min Wu2*, Xinyu Zuo1*, Mixue Xie3*, Xiaoqin Wang, MD4*, Xiu-Jin Ye5*, Shuhong Shen, MD, PhD6 and Yanhui Xie1*

1Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China
2Huadong Hospital Affiliated To Fudan University, Shanghai, CHN
3Department of Hematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
4Affiliated Huashan Hospital of Fudan University, Shanghai, China
5The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
6Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Jing Zhou1*, Xing Chen2*, Yang Cao3*, Liang Huang4 and Gaoxiang Wang5*

1Department of Hematology, Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, Wuhan, China
2tongji hospital, wuhan, China
3Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, Wuhan, China
4Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China
5Department of Hematology, Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, wuhan, China

Sean Wen, BSc, MSc, PhD1,2*, Jennifer O Sullivan3,4*, Joanna Baxter5*, Nikolaos Sousos3,4*, Adam J Mead, MRCP, FRCPath, PhD3,6 and Alba Rodriguez-Meira3,7,8,9*

1Haematopoietic Stem Cell Biology Laboratory, Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Cambridge, ENG, United Kingdom
2Medical Research Council Centre for Computational Biology, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
3NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
4Haematopoietic Stem Cell Biology Laboratory, Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
5Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
6Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
7Medical Research Council (MRC) Weatherall Institute of Molecular Medicine (WIMM) and NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
8Broad Institute of MIT and Harvard, Cambridge, MA
9Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA

Fu Ziyu, PhD1*, Yun Tan, PhD1*, Xiaoguang Xu, PhD1*, Jie Xu2 and Sai-Juan Chen, MD, PhD1*

1Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China
2Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Ilaria Crespiatico1*, Mattia Zaghi, PhD2*, Cristina Mastini, PhD3*, Deborah D'Aliberti, PhD4*, Mario Mauri, PhD3*, Carl Mirko Mercado, MSc3*, Diletta Fontana, PhD5*, Silvia Spinelli, MSc4*, Valentina Crippa, MSc3*, Elena Inzoli, MD6*, Beatrice Manghisi, MD4,6*, Ivan Civettini, MD7,8*, Daniele Ramazzotti, PhD4*, Valentina Fabiola Ilenia Lavoro, MD4,9*, Michele Gengotti, MD10*, Virginia Brambilla, MD11*, Andrea Aroldi, MD12*, Federica Banfi, MSc13*, Cristiana Barone, PhD14*, Roberto Orsenigo, MSc15*, Ludovica Riera, BSc, PhD16*, Mara Riminucci, MD17*, Alessandro Corsi, MD17*, Massimo Breccia18*, Alessandro Morotti, MD, PhD19, Daniela Cilloni, MD19*, Aldo Roccaro, MD, PhD20, Antonio Sacco, MSc21*, Fabio Stagno, MD, PhD22, Marta Serafini, PhD23*, Federica Mottadelli, MSc24*, Giovanni Cazzaniga, PhD25,26, Fabio Pagni, MD27*, Roberto Chiarle, MD16,28, Emanuele Azzoni, PhD14*, Alessandro Sessa2*, Carlo Gambacorti-Passerini, MD7,8, Elena Maria Elli, MD29*, Luca Mologni, PhD7* and Rocco Piazza, MD, PhD4,12*

1Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
2Stem Cell and Neurogenesis Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, ITA
3Department of Medicine and Surgery, University of Milano-Bicocca, Monza, ITA
4Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
5Department of Medicine and Surgery, Università degli Studi Milano-Bicocca, Monza, ITA
6Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, ITA
7Department of Medicine and Surgery, University Milano-Bicocca, Monza, Italy
8Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
9Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, MB, Italy
10Department of Medicine and Surgery, University of Milano - Bicocca, Monza, ITA
11Department of Pathology, University Milan Bicocca, Monza, ITA
12Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
13IRCCS San Raffaele Scientific Institute, Milano, ITA
14Department of Medicine and Surgery, University of Milano Bicocca, Monza, ITA
15Biomedical Research in Melanoma-Animal Models and Cancer Laboratory, Vall D'Hebron Research Institute (VHIR), Vall D'Hebron Hospital Barcelona-Uab, Barcelona, ESP
16Department of Pathology, A.O.U Città della Salute e della Scienza, Torino, Italy
17Department of Molecular Medicine, Az. Policlinico Umberto I, Sapienza University of Rome, ROME, ITA
18Department of Translational and Precision Medicine, Hematology-Sapienza University, Rome, Italy
19Department of Clinical and Biological Sciences, University of Turin, Orbassano, ITA
20Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, BS, Italy
21Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy
22Division of Hematology and Bone Marrow Transplant, AOU Policlinico “Rodolico – San Marco”, Catania, Italy
23Centro Tettamanti, IRCCS San Gerardo dei Tintori, MONZA, ITA
24Centro Tettamanti, IRCCS San Gerardo dei Tintori, Monza, ITA
25Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
26School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
27Department of Pathology, University of Milano-Bicocca, Monza, Italy
28Children's Hospital Boston, Boston, MA
29Hematology Division and Bone Marrow Unit, IRCCS Foundation San Gerardo dei Tintori, Monza, Italy., Monza, Italy

Lucca L.M. Derks, MSc1,2*, Inge Van Der Werf1,2*, Laurianne Trabut, MSc1,2*, Eline Bertrums, MD1,2,3*, Jurrian De Kanter, MSc1,2*, Axel Rosendahl Huber, PhD1,2* and Ruben Van Boxtel, PhD1,2*

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Oncode Institute, Utrecht, Netherlands
3Department of Pediatric Oncology/Hematology, Erasmus Medical Center, Rotterdam, Netherlands

Yuanyuan Ji, Ph.D.*, Jebrail Dempsey, B.S.*, Toby Thomas, B.S.*, Jacob Lark, B.S.*, Albert Son, B.S.* and Stephen Chung, M.D.

Division of Hematology/Oncology, Department of Internal Medicine, Children's Research Institute, University of Texas Southwestern, Dallas, TX

*signifies non-member of ASH